Shuttle Pharmaceuticals Holdings, Inc.
General ticker "SHPH" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $22.5M (TTM average)
Shuttle Pharmaceuticals Holdings, Inc. does not follow the US Stock Market performance with the rate: -20.3%.
Estimated limits based on current volatility of 9.5%: low 1.35$, high 1.63$
Factors to consider:
- Total employees count: 9 (+12.5%) as of 2024
- Top business risk factors: Inability to raise capital, Regulatory and compliance, Failure to obtain approval, Loss of patent protection, Pricing regulations
- Current price 69.0% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.10$, 33.91$]
- 2025-12-31 to 2026-12-31 estimated range: [1.84$, 12.51$]
Financial Metrics affecting the SHPH estimates:
- Negative: with PPE of -0.2 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -3.88 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: 0.01 < Interest expense per share per price, % of 0.64
- Negative: negative Industry operating income (median)
- Negative: -0.75 < Inventory ratio change, % of 0
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term SHPH quotes
Long-term SHPH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $2.34MM | $5.89MM | $7.70MM |
| Operating Income | $-2.34MM | $-5.89MM | $-7.70MM |
| Non-Operating Income | $-2.65MM | $-0.49MM | $-1.14MM |
| Interest Expense | $0.67MM | $2.49MM | $1.21MM |
| R&D Expense | $1.05MM | $3.52MM | $3.62MM |
| Income(Loss) | $-5.00MM | $-6.38MM | $-8.84MM |
| Profit(Loss)* | $-5.00MM | $-6.59MM | $-8.84MM |
| Stockholders Equity | $7.68MM | $4.06MM | $0.71MM |
| Assets | $8.65MM | $5.95MM | $2.51MM |
| Operating Cash Flow | $-2.71MM | $-5.58MM | $-7.33MM |
| Capital expenditure | $0.00MM | $0.02MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $-2.83MM | $2.92MM |
| Financing Cash Flow | $10.62MM | $2.57MM | $3.76MM |
| Earnings Per Share** | $-0.48 | $-0.41 | $-0.86 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.